5 Micro-Cap Stocks to Buy According to Cathie Wood

Page 5 of 5

1. Surface Oncology, Inc. (NASDAQ:SURF)

ARK Investment Management’s Stake Value: $34,961,000

Percentage of ARK Investment Management’s 13F Portfolio: 0.08%

Number of Hedge Fund Holders: 12

Market Capitalization: $251.898 million

Surface Oncology, Inc. (NASDAQ:SURF) is the top micro-cap stock in Cathie Wood’s 13F portfolio for the third quarter, with Wood owning 4.61 million Surface Oncology, Inc. (NASDAQ:SURF) shares, worth $34.96 million, representing 0.08% of her total investments. 

Surface Oncology, Inc. (NASDAQ:SURF) is a company focused on ​​developing next generation immunotherapies targeting the immune-suppressive tumor microenvironment to combat cancer. 

The third quarter earnings were published on November 4 by Surface Oncology, Inc. (NASDAQ:SURF), with the company reporting a loss per share of $0.44, missing estimates by $0.04. 

In Q3 2021, 12 hedge funds reported owning stakes in Surface Oncology, Inc. (NASDAQ:SURF), worth $66.4 million. This is an increase as compared to 10 funds holding stakes in the company valued at $58.78 million in the preceding quarter.

Ken Griffin’s Citadel Investment Group is one of the biggest stakeholders of Surface Oncology, Inc. (NASDAQ:SURF), with 1.45 million shares worth more than $11 million.

You can also take a look at Echo Street Capital Management: Greg Poole’s Top 10 Stock Picks and 10 Dividend Stocks With the Potential to Grow

Page 5 of 5